Stifel Financial’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-25,025
| Closed | -$89.3K | – | 3421 |
|
|
2024
Q3 | $89.3K | Sell |
25,025
-62,582
| -71% | -$223K | ﹤0.01% | 3258 |
|
|
2024
Q2 | $543K | Buy |
87,607
+2,593
| +3% | +$16.1K | ﹤0.01% | 2577 |
|
|
2024
Q1 | $803K | Buy |
85,014
+13,559
| +19% | +$128K | ﹤0.01% | 2323 |
|
|
2023
Q4 | $482K | Buy |
71,455
+43,767
| +158% | +$295K | ﹤0.01% | 2580 |
|
|
2023
Q3 | $123K | Buy |
27,688
+2,200
| +9% | +$9.77K | ﹤0.01% | 3077 |
|
|
2023
Q2 | $84.1K | Sell |
25,488
-8,612
| -25% | -$28.4K | ﹤0.01% | 3193 |
|
|
2023
Q1 | $97.2K | Sell |
34,100
-200
| -0.6% | -$570 | ﹤0.01% | 3178 |
|
|
2022
Q4 | $250K | Buy |
34,300
+1,700
| +5% | +$12.4K | ﹤0.01% | 2868 |
|
|
2022
Q3 | $264K | Buy |
32,600
+8,000
| +33% | +$64.8K | ﹤0.01% | 2804 |
|
|
2022
Q2 | $121K | Buy |
+24,600
| New | +$121K | ﹤0.01% | 3130 |
|